What is the interpretation and recommended management for a patient with a 2‑hour oral glucose tolerance test showing fasting glucose 108 mg/dL and 2‑hour glucose 191 mg/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnosis: Impaired Glucose Tolerance (IGT)

This patient has impaired glucose tolerance (IGT), not diabetes, based on a fasting glucose of 108 mg/dL and 2-hour glucose of 191 mg/dL on the oral glucose tolerance test.

Interpretation of Results

The glucose values fall into specific diagnostic categories according to the most recent ADA guidelines 1, 2:

  • Fasting glucose 108 mg/dL: This is in the impaired fasting glucose (IFG) range (100-125 mg/dL), but does NOT meet diabetes criteria (≥126 mg/dL)
  • 2-hour glucose 191 mg/dL: This is in the impaired glucose tolerance (IGT) range (140-199 mg/dL), but does NOT meet diabetes criteria (≥200 mg/dL)

The patient has both IFG and IGT ("combined glucose intolerance"), which represents a high-risk prediabetic state. This combination carries substantially higher risk for progression to diabetes and cardiovascular disease compared to isolated IFG or isolated IGT alone 3, 4.

Clinical Significance

The 2-hour glucose value is particularly important here. Research demonstrates that 2-hour glucose is a better predictor of cardiovascular mortality and all-cause mortality than fasting glucose 5. The elevated 2-hour value (191 mg/dL) indicates significant insulin resistance, while the mildly elevated fasting glucose suggests some degree of impaired insulin secretion 3.

Important caveat: If this test was performed during pregnancy (24-28 weeks gestation), these values would indicate gestational diabetes mellitus (GDM) using the two-step approach, as the 2-hour value exceeds the 155 mg/dL threshold 6, 2. The context of pregnancy versus non-pregnancy fundamentally changes the diagnosis and management.

Recommended Management (Non-Pregnant Patient)

Immediate Actions:

  1. Intensive lifestyle modification (this is the most effective intervention):

    • Target 5-7% body weight loss if overweight/obese
    • Minimum 150 minutes per week of moderate-intensity physical activity (e.g., brisk walking)
    • Dietary counseling focusing on reduced caloric intake and healthier food choices
  2. Consider metformin therapy if:

    • BMI ≥35 kg/m²
    • Age <60 years
    • History of gestational diabetes
    • Rapidly progressive hyperglycemia despite lifestyle intervention

    Metformin has proven efficacy in preventing progression to diabetes, though lifestyle modification is more effective 7.

  3. Screen for cardiovascular risk factors (this patient population has elevated CV risk):

    • Blood pressure measurement
    • Lipid panel
    • Consider screening for fatty liver disease
  4. Repeat testing in 1 year with fasting glucose, 2-hour OGTT, or HbA1c to monitor for progression to diabetes 1.

Critical Point About Testing Strategy

The 2-hour OGTT value identifies high-risk patients that fasting glucose alone would miss. Studies show that using fasting glucose alone would fail to detect approximately 66% of patients with IGT who have cardiovascular risk profiles 4. This patient's 2-hour value of 191 mg/dL places them at substantially elevated risk that the fasting glucose of 108 mg/dL alone would underestimate.

If This is Gestational Diabetes (Pregnancy Context)

If this OGTT was performed at 24-28 weeks gestation using the two-step approach (100-gram OGTT after positive 50-gram screening), this patient has GDM because the 2-hour value of 191 mg/dL exceeds the Carpenter-Coustan threshold of 155 mg/dL 6, 2.

Management would then include:

  • Immediate initiation of blood glucose monitoring
  • Nutritional counseling
  • Glucose targets: fasting <95 mg/dL, 1-hour postprandial <140 mg/dL, 2-hour postprandial <120 mg/dL
  • Insulin therapy if unable to achieve targets with lifestyle modification alone (80-90% can be managed with lifestyle alone)
  • Postpartum screening at 6-12 weeks with 75-gram OGTT using non-pregnant criteria
  • Lifelong screening for diabetes every 1-3 years thereafter 6, 8

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.